Leading the way to safer medication
 Crosscheck  Recommender

ATC Group: A02BC03 Lansoprazole

Anatomical Therapeutic Chemical Classification System

Hierarchical Position

Level
Code
Title
1
A
Alimentary tract and metabolism
2
A02
Drugs for acid related disorders
3
A02B
DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD)
4
A02BC
Proton pump inhibitors
5
A02BC03
Lansoprazole

Active Ingredients

Chemical substance
Description
Lansoprazole

Lansoprazole is a gastric proton pump inhibitor. It inhibits the final stage of gastric acid formation by inhibiting the activity of H+/K+ ATPase of the parietal cells in the stomach. The inhibition is dose-dependent and reversible, and the effect applies to both basal and stimulated secretion of gastric acid.

Monographs

Monograph
Type
Country
LANSOPRAZOLE Gastro-resistant capsules
MPI, EU: SmPC
UK
PREVACID Delayed-release capsule / Delayed-release tablet
MPI, US: SPL/PLR
US
ZOTON FASTAB Oro-dispersible tablet
MPI, EU: SmPC
UK